Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · Real-Time Price · USD
2.400
-0.260 (-9.77%)
Apr 1, 2025, 10:20 AM EDT - Market open
Company Description
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.
It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone.
The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Sintx Technologies, Inc.
| Country | United States |
| Founded | 1996 |
| IPO Date | Feb 13, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 20 |
| CEO | Eric Olson |
Contact Details
Address: 1885 West 2100 South Salt Lake City, Utah 84119 United States | |
| Phone | 801 839 3500 |
| Website | sintx.com |
Stock Details
| Ticker Symbol | SINT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001269026 |
| CUSIP Number | 829392307 |
| ISIN Number | US8293926049 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Eric K. Olson | President, Chief Executive Officer and Chairman of the Board |
| Dr. Ryan Bock Ph.D. | Chief Technology Officer |
| Gregg Richard Honigblum | Chief Strategy Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2025 | EFFECT | Notice of Effectiveness |
| Mar 25, 2025 | SCHEDULE 13G | Filing |
| Mar 25, 2025 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Mar 19, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Mar 19, 2025 | 10-K | Annual Report |
| Mar 13, 2025 | 8-K | Current Report |
| Feb 27, 2025 | 144 | Filing |
| Feb 26, 2025 | 8-K | Current Report |
| Feb 20, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |